Skip to main content
SpringerLink
Log in

Progranulin/GP88, A Complex and Multifaceted Player of Tumor Growth by Direct Action and via the Tumor Microenvironment

  • Chapter
  • First Online:
Tumor Microenvironment

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1329))

Abstract

Investigation of the role of progranulin/GP88 on the proliferation and survival of a wide variety of cells has been steadily increasing. Several human diseases stem from progranulin dysregulation either through its overexpression in cancer or its absence as in the case of null mutations in some form of frontotemporal dementia. The present review focuses on the role of progranulin/GP88 in cancer development, progression, and drug resistance. Various aspects of progranulin identification, biology, and signaling pathways will be described. Information will be provided about its direct role as an autocrine growth and survival factor and its paracrine effect as a systemic factor as well as via interaction with extracellular matrix proteins and with components of the tumor microenvironment to influence drug resistance, migration, angiogenesis, inflammation, and immune modulation. This chapter will also describe studies examining progranulin/GP88 tumor tissue expression as well as circulating level as a prognostic factor for several cancers. Due to the wealth of publications in progranulin, this review does not attempt to be exhaustive but rather provide a thread to lead the readers toward more in-depth exploration of this fascinating and unique protein.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abdulrahman A, Eckstein M, Jung R, Guzman J, Weigelt K, Serrero G, Yue B, Geppert C, Stohr R, Hartmann A, Wullich B, Wach S, Taubert H, Lieb V (2019) Expression of GP88 (Progranulin) protein is an independent prognostic factor in prostate cancer patients. Cancers (Basel) 11(12):1–13

    Google Scholar 

  2. Abrhale T, Brodie A, Sabnis G, Macedo L, Tian C, Yue B, Serrero G (2011) GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells. BMC Cancer 11:231

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ansell SM, Vonderheide RH (2013) Cellular composition of the tumor microenvironment. Am Soc Clin Oncol Educ Book 33:e91–e97

    Article  Google Scholar 

  4. Arango Duque G, Descoteaux A (2014) Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol 5:491–491

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Arechavaleta-Velasco F, Perez-Juarez CE, Gerton GL, Diaz-Cueto L (2017) Progranulin and its biological effects in cancer. Med Oncol 34(12):194

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Arneth B (2019) Tumor Microenvironment. Medicina (Kaunas) 56(1):15

    Google Scholar 

  7. Baba T, Hoff HB 3rd, Nemoto H, Lee H, Orth J, Arai Y, Gerton GL (1993) Acrogranin, an acrosomal cysteine-rich glycoprotein, is the precursor of the growth-modulating peptides, granulins, and epithelins, and is expressed in somatic as well as male germ cells. Mol Reprod Dev 34(3):233–243

    Article  CAS  PubMed  Google Scholar 

  8. Balkwill F, Montfort A, Capasso M (2013) B regulatory cells in cancer. Trends Immunol 34(4):169–173

    Article  CAS  PubMed  Google Scholar 

  9. Balkwill FR, Capasso M, Hagemann T (2012) The tumor microenvironment at a glance. J Cell Sci 125(Pt 23):5591–5596

    Article  CAS  PubMed  Google Scholar 

  10. Bandey I, Chiou SH, Huang AP, Tsai JC, Tu PH (2015) Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness. Oncogene 34(14):1853–1864

    Article  CAS  PubMed  Google Scholar 

  11. Barnes D, McKeehan WL, Sato GH (1987) Cellular endocrinology: integrated physiology in vitro. In Vitro Cell Dev Biol 23(10):659–662

    Article  CAS  PubMed  Google Scholar 

  12. Barnes D, Sato G (1980) Serum-free cell culture: a unifying approach. Cell 22(3):649–655

    Article  CAS  PubMed  Google Scholar 

  13. Bateman A, Belcourt D, Bennett H, Lazure C, Solomon S (1990) Granulins, a novel class of peptide from leukocytes. Biochem Biophys Res Commun 173(3):1161–1168

    Article  CAS  PubMed  Google Scholar 

  14. Bateman A, Chitramuthu BP, Bennett HPJ (2018) Chromatographic Methods for the Purification of Granulin Peptides. Methods Mol Biol 1806:19–34

    Article  CAS  PubMed  Google Scholar 

  15. Bettger WJ, Ham RG (1982) The nutrient requirements of cultured mammalian cells. Adv Nutr Res 4:249–286

    Article  CAS  PubMed  Google Scholar 

  16. Bhandari V, Bateman A (1992) Structure and chromosomal location of the human granulin gene. Biochem Biophys Res Commun 188(1):57–63

    Article  CAS  PubMed  Google Scholar 

  17. Bhandari V, Palfree RG, Bateman A (1992) Isolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domains. Proc Natl Acad Sci U S A 89(5):1715–1719

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, Vonderheide RH, Pittet MJ, Jain RK, Zou W, Howcroft TK, Woodhouse EC, Weinberg RA, Krummel MF (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24(5):541–550

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Birbrair A, Zhang T, Wang ZM, Messi ML, Olson JD, Mintz A, Delbono O (2014) Type-2 pericytes participate in normal and tumoral angiogenesis. Am J Physiol Cell Physiol 307(1):C25–C38

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Bissell MJ (2017) Goodbye flat biology - time for the 3rd and the 4th dimensions. J Cell Sci 130(1):3–5

    Article  CAS  PubMed  Google Scholar 

  21. Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1(1):46–54

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bose D, Zimmerman LJ, Pierobon M, Petricoin E, Tozzi F, Parikh A, Fan F, Dallas N, Xia L, Gaur P, Samuel S, Liebler DC, Ellis LM (2011) Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells. Br J Cancer 105(11):1759–1767

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Bottenstein J, Hayashi I, Hutchings S, Masui H, Mather J, McClure DB, Ohasa S, Rizzino A, Sato G, Serrero G, Wolfe R, Wu R (1979) The growth of cells in serum-free hormone-supplemented media. Methods Enzymol 58:94–109

    Article  CAS  PubMed  Google Scholar 

  24. Boxberg M, Leising L, Steiger K, Jesinghaus M, Alkhamas A, Mielke M, Pfarr N, Götz C, Wolff KD, Weichert W, Kolk A (2019) Composition and clinical impact of the immunologic tumor microenvironment in oral squamous cell carcinoma. J Immunol 202(1):278–291

    Article  CAS  PubMed  Google Scholar 

  25. Buonassisi V, Sato G, Cohen AI (1962) Hormone-producing cultures of adrenal and pituitary tumor origin. Proc Natl Acad Sci U S A 48:1184–1190

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Buraschi S, Xu SQ, Stefanello M, Moskalev I, Morcavallo A, Genua M, Tanimoto R, Birbe R, Peiper SC, Gomella LG, Belfiore A, Black PC, Iozzo RV, Morrione A (2016) Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin. Oncotarget 7(26):39980–39995

    Article  PubMed  PubMed Central  Google Scholar 

  27. Caesar M, Felk S, Zach S, Bronstad G, Aasly JO, Gasser T, Gillardon F (2014) Changes in matrix metalloprotease activity and progranulin levels may contribute to the pathophysiological function of mutant leucine-rich repeat kinase 2. Glia 62(7):1075–1092

    Article  PubMed  Google Scholar 

  28. Chen X, Chang J, Deng Q, Xu J, Nguyen TA, Martens LH, Cenik B, Taylor G, Hudson KF, Chung J, Yu K, Yu P, Herz J, Farese RV Jr, Kukar T, Tansey MG (2013) Progranulin does not bind tumor necrosis factor (TNF) receptors and is not a direct regulator of TNF-dependent signaling or bioactivity in immune or neuronal cells. J Neurosci 33(21):9202–9213

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Chen YQ, Wang CJ, Xie K, Lei M, Chai YS, Xu F, Lin SH (2020) Progranulin Improves Acute Lung Injury through Regulating the Differentiation of Regulatory T Cells and Interleukin-10 Immunomodulation to Promote Macrophage Polarization. Mediat Inflamm 2020:9704327

    Article  Google Scholar 

  30. Cheng L, Ramesh AV, Flesken-Nikitin A, Choi J, Nikitin AY (2010) Mouse models for cancer stem cell research. Toxicol Pathol 38(1):62–71

    Article  PubMed  Google Scholar 

  31. Cheung PF, Cheung TT, Yip CW, Ng LW, Fung SW, Lo CM, Fan ST, Cheung ST (2016) Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma. Oncotarget 7(16):21644–21657

    Article  PubMed  PubMed Central  Google Scholar 

  32. Cheung PF, Yip CW, Wong NC, Fong DY, Ng LW, Wan AM, Wong CK, Cheung TT, Ng IO, Poon RT, Fan ST, Cheung ST (2014) Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity. Cancer Immunol Res 2(12):1209–1219

    Article  CAS  PubMed  Google Scholar 

  33. Cheung ST, Wong SY, Leung KL, Chen X, So S, Ng IO, Fan ST (2004) Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Clin Cancer Res 10(22):7629–7636

    Article  CAS  PubMed  Google Scholar 

  34. Choi JP, Park SY, Moon KA, Ha EH, Woo YD, Chung DH, Kwon HS, Kim TB, Park HS, Moon HB, Song WJ, Cho YS (2020) Macrophage-derived progranulin promotes allergen-induced airway inflammation. Allergy 75(5):1133–1145

    Article  CAS  PubMed  Google Scholar 

  35. Darmon M, Serrero G, Rizzino A, Sato G (1981) Isolation of myoblastic, fibro-adipogenic, and fibroblastic clonal cell lines from a common precursor and study of their requirements for growth and differentiation. Exp Cell Res 132(2):313–327

    Article  CAS  PubMed  Google Scholar 

  36. Daya M, Loilome W, Techasen A, Thanee M, Sa-Ngiamwibool P, Titapun A, Yongvanit P, Namwat N (2018) Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway. Onco Targets Ther 11:395–408

    Article  PubMed  PubMed Central  Google Scholar 

  37. Demorrow S (2013) Progranulin: a novel regulator of gastrointestinal cancer progression. Transl Gastrointest Cancer 2(3):145–151

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Devoogdt N, Hassanzadeh Ghassabeh G, Zhang J, Brys L, De Baetselier P, Revets H (2003) Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells. Proc Natl Acad Sci U S A 100(10):5778–5782

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Díaz-Cueto L, Stein P, Jacobs A, Schultz RM, Gerton GL (2000) Modulation of mouse preimplantation embryo development by acrogranin (epithelin/granulin precursor). Dev Biol 217(2):406–418

    Article  PubMed  CAS  Google Scholar 

  40. Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L (2002) Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8(8):793–800

    Article  CAS  PubMed  Google Scholar 

  41. Eguchi R, Nakano T, Wakabayashi I (2017) Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells. Oncogene 36(5):714–722

    Article  CAS  PubMed  Google Scholar 

  42. Elkabets M, Brook S (2018) Methods to study the role of progranulin in the tumor microenvironment. Methods Mol Biol 1806:155–176

    Article  CAS  PubMed  Google Scholar 

  43. Elkabets M, Gifford AM, Scheel C, Nilsson B, Reinhardt F, Bray MA, Carpenter AE, Jirström K, Magnusson K, Ebert BL, Pontén F, Weinberg RA, McAllister SS (2011) Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J Clin Invest 121(2):784–799

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Erin N, Grahovac J, Brozovic A, Efferth T (2020) Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. Drug Resist Updat 53:100715

    Google Scholar 

  45. Feig C, Jones JO, Kraman M, Wells RJ, Deonarine A, Chan DS, Connell CM, Roberts EW, Zhao Q, Caballero OL, Teichmann SA, Janowitz T, Jodrell DI, Tuveson DA, Fearon DT (2013) Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci U S A 110(50):20212–20217

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Feng T, Zheng L, Liu F, Xu X, Mao S, Wang X, Liu J, Lu Y, Zhao W, Yu X, Tang W (2016) Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway. Oncotarget 7(36):58381–58395

    Article  PubMed  PubMed Central  Google Scholar 

  47. Frampton G, Invernizzi P, Bernuzzi F, Pae HY, Quinn M, Horvat D, Galindo C, Huang L, McMillin M, Cooper B, Rimassa L, DeMorrow S (2012a) Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism. Gut 61(2):268–277

    Article  CAS  PubMed  Google Scholar 

  48. Frampton G, Ueno Y, Quinn M, McMillin M, Pae HY, Galindo C, Leyva-Illades D, DeMorrow S (2012b) The novel growth factor, progranulin, stimulates mouse cholangiocyte proliferation via sirtuin-1-mediated inactivation of FOXO1. Am J Physiol Gastrointest Liver Physiol 303(11):G1202–G1211

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12(4):253–268

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Gardner A, de Mingo Pulido Á, Ruffell B (2020) Dendritic cells and their role in immunotherapy. Front Immunol 11:924

    Google Scholar 

  51. Ghidoni R, Flocco R, Paterlini A, Glionna M, Caruana L, Tonoli E, Binetti G, Benussi L (2014) Secretory leukocyte protease inhibitor protein regulates the penetrance of frontotemporal lobar degeneration in progranulin mutation carriers. J Alzheimers Dis 38(3):533–539

    Article  CAS  PubMed  Google Scholar 

  52. Gonzalez EM, Mongiat M, Slater SJ, Baffa R, Iozzo RV (2003) A novel interaction between perlecan protein core and progranulin: potential effects on tumor growth. J Biol Chem 278(40):38113–38116

    Article  CAS  PubMed  Google Scholar 

  53. Goswami KK, Ghosh T, Ghosh S, Sarkar M, Bose A, Baral R (2017) Tumor promoting role of anti-tumor macrophages in tumor microenvironment. Cell Immunol 316:1–10

    Article  CAS  PubMed  Google Scholar 

  54. Greither T, Fischer K, Theil G, Marcou M, Holzhausen HJ, Weigelt K, Serrero G, Hicks D, Yue B, Fornara P, Wullich B, Taubert H, Wach S, Lieb V (2018) Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival. Cancer Manag Res 10:4173–4180

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Guo F, Lai Y, Tian Q, Lin EA, Kong L, Liu C (2010) Granulin-epithelin precursor binds directly to ADAMTS-7 and ADAMTS-12 and inhibits their degradation of cartilage oligomeric matrix protein. Arthritis Rheum 62(7):2023–2036

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Ham RG (1965) Clonal growth of mammalian cells in a chemically defined, synthetic medium. Proc Natl Acad Sci U S A 53(2):288–293

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Ham RG, McKeehan WL (1979) Media and growth requirements. Methods Enzymol 58:44–93

    Article  CAS  PubMed  Google Scholar 

  58. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70

    Article  CAS  PubMed  Google Scholar 

  59. Hanington PC, Barreda DR, Belosevic M (2006) A novel hematopoietic granulin induces proliferation of goldfish (Carassius auratus L.) macrophages. J Biol Chem 281(15):9963–9970

    Article  CAS  PubMed  Google Scholar 

  60. Hayashi I, Sato GH (1976) Replacement of serum by hormones permits growth of cells in a defined medium. Nature 259(5539):132–134

    Article  CAS  PubMed  Google Scholar 

  61. He Z, Bateman A (2003) Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med (Berl) 81(10):600–612

    Article  CAS  Google Scholar 

  62. He Z, Ismail A, Kriazhev L, Sadvakassova G, Bateman A (2002) Progranulin (PC-cell-derived growth factor/acrogranin) regulates invasion and cell survival. Cancer Res 62(19):5590–5596

    CAS  PubMed  Google Scholar 

  63. Hu SY, Tai CC, Li YH, Wu JL (2012) Progranulin compensates for blocked IGF-1 signaling to promote myotube hypertrophy in C2C12 myoblasts via the PI3K/Akt/mTOR pathway. FEBS Lett 586(19):3485–3492

    Article  CAS  PubMed  Google Scholar 

  64. Huang H, Li J, Lu Y, Min L, Li D, Dai L (2015) Role of midkine-progranulin interaction during angiogenesis of hepatocellular carcinoma. Int J Clin Exp Pathol 8(8):8809–8820

    PubMed  PubMed Central  Google Scholar 

  65. Huang K, Huang C, Shan K, Chen J, Li H (2012) Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma. Clin Exp Dermatol 37(4):411–417

    Article  CAS  PubMed  Google Scholar 

  66. Jian J, Zhao S, Tian Q, Gonzalez-Gugel E, Mundra JJ, Uddin SM, Liu B, Richbourgh B, Brunetti R, Liu CJ (2013) Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains. FEBS Lett 587(21):3428–3436

    Article  CAS  PubMed  Google Scholar 

  67. Jones MB, Michener CM, Blanchette JO, Kuznetsov VA, Raffeld M, Serrero G, Emmert-Buck MR, Petricoin EF, Krizman DB, Liotta LA, Kohn EC (2003) The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. Clin Cancer Res 9(1):44–51

    CAS  PubMed  Google Scholar 

  68. Jung J, Seol HS, Chang S (2018) The Generation and Application of Patient-Derived Xenograft Model for Cancer Research. Cancer Res Treat 50(1):1–10

    Article  PubMed  CAS  Google Scholar 

  69. Kandalaft LE, Motz GT, Busch J, Coukos G (2011) Angiogenesis and the tumor vasculature as antitumor immune modulators: the role of vascular endothelial growth factor and endothelin. Curr Top Microbiol Immunol 344:129–148

    CAS  PubMed  Google Scholar 

  70. Kawamoto T, Sato GH, Takahashi K, Nishi M, Taniguchi S, Sato JD (1990) Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function. Cytotechnology 3(3):279–293

    Article  CAS  PubMed  Google Scholar 

  71. Kawamoto T, Sato JD, Le A, Polikoff J, Sato GH, Mendelsohn J (1983) Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci U S A 80(5):1337–1341

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Kessenbrock K, Frohlich L, Sixt M, Lammermann T, Pfister H, Bateman A, Belaaouaj A, Ring J, Ollert M, Fassler R, Jenne DE (2008) Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest 118(7):2438–2447

    CAS  PubMed  PubMed Central  Google Scholar 

  73. Kim WE, Serrero G (2006) PC cell-derived growth factor stimulates proliferation and confers Trastuzumab resistance to Her-2-overexpressing breast cancer cells. Clin Cancer Res 12(14 Pt 1):4192–4199

    Article  CAS  PubMed  Google Scholar 

  74. Kim WE, Yue B, Serrero G (2015) Signaling pathway of GP88 (Progranulin) in breast cancer cells: upregulation and phosphorylation of c-myc by GP88/progranulin in Her2-overexpressing breast cancer cells. Breast Cancer (Auckl) 9(Suppl 2):71–77

    CAS  Google Scholar 

  75. Kleinberger G, Capell A, Brouwers N, Fellerer K, Sleegers K, Cruts M, Van Broeckhoven C, Haass C (2016) Reduced secretion and altered proteolytic processing caused by missense mutations in progranulin. Neurobiol Aging 39(220):e217–e226

    Google Scholar 

  76. Koo DH, Do IG, Oh S, Lee YG, Kim K, Sohn JH, Park SK, Yang HJ, Jung YS, Park DI, Jeong KU, Kim HO, Kim H, Serrero G, Chun HK, Team KCC (2020) Prognostic value of progranulin in patients with colorectal cancer treated with curative resection. Pathol Oncol Res 26(1):397–404

    Article  CAS  PubMed  Google Scholar 

  77. Koo DH, Park CY, Lee ES, Ro J, Oh SW (2012) Progranulin as a prognostic biomarker for breast cancer recurrence in patients who had hormone receptor-positive tumors: a cohort study. PLoS One 7(6):e39880

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Kudoh K, Ramanna M, Ravatn R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS, Chin KV (2000) Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res 60(15):4161–4166

    CAS  PubMed  Google Scholar 

  79. Kulbe H, Chakravarty P, Leinster DA, Charles KA, Kwong J, Thompson RG, Coward JI, Schioppa T, Robinson SC, Gallagher WM, Galletta L, Study GAOC, Salako MA, Smyth JF, Hagemann T, Brennan DJ, Bowtell DD, Balkwill FR (2012) A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment. Cancer Res 72(1):66–75

    Article  CAS  PubMed  Google Scholar 

  80. Lam CY, Yip CW, Poon TC, Cheng CK, Ng EW, Wong NC, Cheung PF, Lai PB, Ng IO, Fan ST, Cheung ST (2012) Identification and characterization of tropomyosin 3 associated with granulin-epithelin precursor in human hepatocellular carcinoma. PLoS One 7(7):e40324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Lamagna C, Aurrand-Lions M, Imhof BA (2006) Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol 80(4):705–713

    Article  CAS  PubMed  Google Scholar 

  82. Laudisi F, Cherubini F, Di Grazia A, Dinallo V, Di Fusco D, Franze E, Ortenzi A, Salvatori I, Scaricamazza S, Monteleone I, Sakamoto N, Monteleone G, Stolfi C (2019) Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells. Mol Oncol 13(10):2142–2159

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Lee CW, Stankowski JN, Chew J, Cook CN, Lam YW, Almeida S, Carlomagno Y, Lau KF, Prudencio M, Gao FB, Bogyo M, Dickson DW, Petrucelli L (2017) The lysosomal protein cathepsin L is a progranulin protease. Mol Neurodegener 12(1):55

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  84. Lei Z-G, Ren X-H, Wang S-S, Liang X-H, Tang Y-L (2016) Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma. Onco Targets Ther 9:545–555

    CAS  PubMed  PubMed Central  Google Scholar 

  85. Li G, Dong T, Yang D, Gao A, Luo J, Yang H, Wang L (2018) Progranulin promotes lymphangiogenesis through VEGF-C and is an independent risk factor in human esophageal cancers. Hum Pathol 75:116–124

    Article  CAS  PubMed  Google Scholar 

  86. Liu F, Zhang W, Yang F, Feng T, Zhou M, Yu Y, Yu X, Zhao W, Yi F, Tang W, Lu Y (2016) Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling. Sci Rep 6:21260

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Liu Y, Xi L, Liao G, Wang W, Tian X, Wang B, Chen G, Han Z, Wu M, Wang S, Zhou J, Xu G, Lu Y, Ma D (2007) Inhibition of PC cell-derived growth factor (PCDGF)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2. BMC Cancer 7:22

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  88. Lovat F, Bitto A, Xu SQ, Fassan M, Goldoni S, Metalli D, Wubah V, McCue P, Serrero G, Gomella LG, Baffa R, Iozzo RV, Morrione A (2009) Proepithelin is an autocrine growth factor for bladder cancer. Carcinogenesis 30(5):861–868

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Lu R, Serrero G (2001) Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor). Proc Natl Acad Sci U S A 98(1):142–147

    Article  CAS  PubMed  Google Scholar 

  90. Lu T, Gabrilovich DI (2012) Molecular pathways: tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment. Clin Cancer Res 18(18):4877–4882

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Lu Y, Zheng L, Zhang W, Feng T, Liu J, Wang X, Yu Y, Qi M, Zhao W, Yu X, Tang W (2014) Growth factor progranulin contributes to cervical cancer cell proliferation and transformation in vivo and in vitro. Gynecol Oncol 134(2):364–371

    Article  CAS  PubMed  Google Scholar 

  92. Ma Y, Shurin GV, Peiyuan Z, Shurin MR (2013) Dendritic cells in the cancer microenvironment. J Cancer 4(1):36–44

    Article  CAS  PubMed  Google Scholar 

  93. Marcus PI, Sato GH, Ham RG, Patterson D (2006) A tribute to Dr. Theodore T. Puck (September 24, 1916-November 6, 2005). In Vitro Cell Dev Biol Anim 42(8–9):235–241

    PubMed  Google Scholar 

  94. Motz GT, Coukos G (2011) The parallel lives of angiogenesis and immunosuppression: cancer and other tales. Nat Rev Immunol 11(10):702–711

    Article  CAS  PubMed  Google Scholar 

  95. Neill T, Buraschi S, Goyal A, Sharpe C, Natkanski E, Schaefer L, Morrione A, Iozzo RV (2016) EphA2 is a functional receptor for the growth factor progranulin. J Cell Biol 215(5):687–703

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Ong CH, Bateman A (2003) Progranulin (granulin-epithelin precursor, PC-cell derived growth factor, acrogranin) in proliferation and tumorigenesis. Histol Histopathol 18(4):1275–1288

    CAS  PubMed  Google Scholar 

  97. Ong CH, He Z, Kriazhev L, Shan X, Palfree RG, Bateman A (2006) Regulation of progranulin expression in myeloid cells. Am J Physiol Regul Integr Comp Physiol 291(6):R1602–R1612

    Article  CAS  PubMed  Google Scholar 

  98. Pan Y, Cheung ST, Tong JHM, Tin KY, Kang W, Lung RWM, Wu F, Li H, Ng SSM, Mak TWC, K. F. To, Chan AWH (2018) Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway. J Transl Med 16(1):150

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Park MY, Park YS, Nam JH (2011) RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent. Int J Oncol 39(4):853–861

    CAS  PubMed  Google Scholar 

  100. Perez-Juarez CE, Arechavaleta-Velasco F, Zeferino-Toquero M, Alvarez-Arellano L, Estrada-Moscoso I, Diaz-Cueto L (2019) Inhibition of PI3K/AKT/mTOR and MAPK signaling pathways decreases progranulin expression in ovarian clear cell carcinoma (OCCC) cell line: a potential biomarker for therapy response to signaling pathway inhibitors. Med Oncol 37(1):4

    Article  PubMed  CAS  Google Scholar 

  101. Pizarro GO, Zhou XC, Koch A, Gharib M, Raval S, Bible K, Jones MB (2007) Prosurvival function of the granulin-epithelin precursor is important in tumor progression and chemoresponse. Int J Cancer 120(11):2339–2343

    Article  CAS  PubMed  Google Scholar 

  102. Plowman GD, Green JM, Neubauer MG, Buckley SD, McDonald VL, Todaro GJ, Shoyab M (1992) The epithelin precursor encodes two proteins with opposing activities on epithelial cell growth. J Biol Chem 267(18):13073–13078

    Article  CAS  PubMed  Google Scholar 

  103. Prazeres PHDM, Leonel C, Silva WN, Rocha BGS, Santos GSP, Costa AC, Picoli CC, Sena IFG, Gonçalves WA, Vieira MS, Costa PAC, Campos LMCC, Lopes MTP, Costa MR, Resende RR, Cunha TM, Mintz A, Birbrair A (2020) Ablation of sensory nerves favours melanoma progression. J Cell Mol Med 00:1–16

    Google Scholar 

  104. Rasool N, LaRochelle W, Zhong H, Ara G, Cohen J, Kohn EC (2010) Secretory leukocyte protease inhibitor antagonizes paclitaxel in ovarian cancer cells. Clin Cancer Res 16(2):600–609

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Sato G (1974) The establishment of hormone-dependent cell lines. Methods Enzymol 32:557–561

    Article  CAS  PubMed  Google Scholar 

  106. Sato G (2008) Tissue culture: the unrealized potential. Cytotechnology 57(2):111–114

    Article  PubMed  Google Scholar 

  107. Sato G, Augusti-Tocco G, Posner M (1970) Hormone-secreting and hormone-responsive cell cultures. Recent Prog Horm Res 26:539–546

    CAS  PubMed  Google Scholar 

  108. Sato G, Zaroff L, Mills SE (1960) Tissue culture populations and their relation to the tissue of origin. Proc Natl Acad Sci U S A 46(7):963–972

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Sato GH (1988) Cellular endocrinology and cancer. Prog Clin Biol Res 262:199–206

    CAS  PubMed  Google Scholar 

  110. Sato GH, Sato JD, Okamoto T, McKeehan WL, Barnes DW (2010) Tissue culture: the unlimited potential. In Vitro Cell Dev Biol Anim 46(7):590–594

    Article  PubMed  Google Scholar 

  111. Sato GH, Yasumura Y (1966) Retention of differentiated function in dispersed cell culture. Trans N Y Acad Sci 28(8):1063–1079

    Article  CAS  PubMed  Google Scholar 

  112. Sato JD, Kawamoto T, Le AD, Mendelsohn J, Polikoff J, Sato GH (1983) Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol Biol Med 1(5):511–529

    CAS  PubMed  Google Scholar 

  113. Selmy MA, Ibrahim GH, El Serafi TI, Ghobeish AA (2010) Evaluation of urinary proepithelin as a potential biomarker for bladder cancer detection and prognosis in Egyptian patients. Cancer Biomark 7:163–170

    Article  CAS  PubMed  Google Scholar 

  114. Serrero G (1985) Tumorigenicity associated with loss of differentiation and of response to insulin in the adipogenic cell line 1246. Vitro Cell Dev Biol 21(9):537–540

    Article  CAS  Google Scholar 

  115. Serrero G (2003) Autocrine growth factor revisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesis. Biochem Biophys Res Commun 308(3):409–413

    Article  CAS  PubMed  Google Scholar 

  116. Serrero G (2016) Potential of theranostic target mining in the development of novel diagnostic and therapeutic products in oncology: progranulin/GP88 as a therapeutic and diagnostic target for breast and lung cancers. Rinsho Byori 64(11):1296–1309

    CAS  PubMed  Google Scholar 

  117. Serrero G, Hawkins DM, Bejarano PA, Ioffe O, Tkaczuk KR, Elliott RE, Head JF, Phillips J, Godwin AK, Weaver J, Hicks D, Yue B (2016) Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index. Diagn Pathol 11(1):71

    Article  PubMed  PubMed Central  Google Scholar 

  118. Serrero G, Hawkins DM, Yue B, Ioffe O, Bejarano P, Phillips JT, Head JF, Elliott RL, Tkaczuk KR, Godwin AK, Weaver J, Kim WE (2012) Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma. Breast Cancer Res 14(1):R26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. Serrero G, Hicks D (2018a) Immunohistochemical detection of progranulin (PGRN/GP88/GEP) in tumor tissues as a cancer prognostic biomarker. Methods Mol Biol 1806:107–120

    Article  CAS  PubMed  Google Scholar 

  120. Serrero G, Hicks D (2018b) Measurement of Circulating Progranulin (PGRN/GP88/GEP) by Enzyme-Linked Immunosorbent Assay and Application in Human Diseases. Methods Mol Biol 1806:95–105

    Article  CAS  PubMed  Google Scholar 

  121. Serrero G, Khoo JC (1982) An in vitro model to study adipose differentiation in serum-free medium. Anal Biochem 120(2):351–359

    Article  CAS  PubMed  Google Scholar 

  122. Serrero G, Lepak NM, Hayashi J, Eisinger DP (1992) Effect of testosterone on the growth properties and on epidermal growth factor receptor expression in the teratoma-derived tumorigenic cell line 1246-3A. Cancer Res 52(15):4242–4247

    CAS  PubMed  Google Scholar 

  123. Serrero G, Mills D (1987) Differentiation of newborn rat adipocyte precursors in defined serum-free medium. Vitro Cell Dev Biol 23(1):63–66

    Article  CAS  Google Scholar 

  124. Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Takeyama H (2015) Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth. Cancers (Basel) 7(4):2443–2458

    Article  Google Scholar 

  125. Shipley GD, Ham RG (1981) Improved medium and culture conditions for clonal growth with minimal serum protein and for enhanced serum-free survival of Swiss 3T3 cells. In Vitro 17(8):656–670

    Article  CAS  PubMed  Google Scholar 

  126. Shoyab M, McDonald VL, Byles C, Todaro GJ, Plowman GD (1990) Epithelins 1 and 2: isolation and characterization of two cysteine-rich growth-modulating proteins. Proc Natl Acad Sci U S A 87(20):7912–7916

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Simpkins FA, Devoogdt NM, Rasool N, Tchabo NE, Alejandro EU, Kamrava MM, Kohn EC (2008) The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells. Carcinogenesis 29(3):466–472

    Article  CAS  PubMed  Google Scholar 

  128. Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M, Marini F (2009) Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4(4):e4992

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  129. Sporn MB, Roberts AB (1985a) Autocrine growth factors and cancer. Nature 313(6005):745–747

    Article  CAS  PubMed  Google Scholar 

  130. Sporn MB, Roberts AB (1985b) Autocrine, paracrine and endocrine mechanisms of growth control. Cancer Surv 4(4):627–632

    CAS  PubMed  Google Scholar 

  131. Sporn MB, Roberts AB (1992) Autocrine secretion–10 years later. Ann Intern Med 117(5):408–414

    Article  CAS  PubMed  Google Scholar 

  132. Suh HS, Choi N, Tarassishin L, Lee SC (2012) Regulation of progranulin expression in human microglia and proteolysis of progranulin by matrix metalloproteinase-12 (MMP-12). PLoS One 7(4):e35115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. Swamydas M, Nguyen D, Allen LD, Eddy J, Dreau D (2011) Progranulin stimulated by LPA promotes the migration of aggressive breast cancer cells. Cell Commun Adhes 18(6):119–130

    Article  CAS  PubMed  Google Scholar 

  134. Tanaka M, Iwakiri Y (2016) The hepatic lymphatic vascular system: structure, function, markers, and lymphangiogenesis. Cell Mol Gastroenterol Hepatol 2(6):733–749

    Article  PubMed  PubMed Central  Google Scholar 

  135. Tangkeangsirisin W, Hayashi J, Serrero G (2004) PC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cells. Cancer Res 64(5):1737–1743

    Article  CAS  PubMed  Google Scholar 

  136. Tangkeangsirisin W, Serrero G (2004) PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis 25(9):1587–1592

    Article  CAS  PubMed  Google Scholar 

  137. Tangkeangsirisin, W. a. S., G. (2014) GP88 (Progranulin) confers Fulvestrant (Faslodex, ICI 182,780) resistance to human breast cancer cells. Adv Breast Cancer Res 3:68–78

    Article  CAS  Google Scholar 

  138. Tanimoto R, Morcavallo A, Terracciano M, Xu SQ, Stefanello M, Buraschi S, Lu KG, Bagley DH, Gomella LG, Scotlandi K, Belfiore A, Iozzo RV, Morrione A (2015) Sortilin regulates progranulin action in castration-resistant prostate cancer cells. Endocrinology 156(1):58–70

    Article  PubMed  CAS  Google Scholar 

  139. Tkaczuk KHR, Hawkins D, Yue B, Hicks D, Tait N, Serrero G (2020) Association of serum progranulin levels with disease progression, therapy response and survival in patients with metastatic breast cancer. Clin Breast Cancer 20(3):220–227

    Article  CAS  PubMed  Google Scholar 

  140. Toh H, Daniels E, Bateman A (2018) Methods to investigate the roles of progranulin in angiogenesis using in vitro strategies and transgenic mouse models. Methods Mol Biol 1806:329–360

    Article  CAS  PubMed  Google Scholar 

  141. Ungurs MJ, Sinden NJ, Stockley RA (2014) Progranulin is a substrate for neutrophil-elastase and proteinase-3 in the airway and its concentration correlates with mediators of airway inflammation in COPD. Am J Physiol Lung Cell Mol Physiol 306(1):L80–L87

    Article  CAS  PubMed  Google Scholar 

  142. Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L (2012) Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 12(4):239–252

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  143. Wang J, Li D, Cang H, Guo B (2019) Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment. Cancer Med 8(10):4709–4721

    Article  PubMed  PubMed Central  Google Scholar 

  144. Wang J, Van Damme P, Cruchaga C, Gitcho MA, Vidal JM, Seijo-Martinez M, Wang L, Wu JY, Robberecht W, Goate A (2010) Pathogenic cysteine mutations affect progranulin function and production of mature granulins. J Neurochem 112(5):1305–1315

    Article  CAS  PubMed  Google Scholar 

  145. Wang L, Yang D, Tian J, Gao A, Shen Y, Ren X, Li X, Jiang G, Dong T (2017) Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer. Oncotarget 8(16):26323–26333

    Article  PubMed  PubMed Central  Google Scholar 

  146. Wang W, Hayashi J, Serrero G (2006) PC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myeloma. Clin Cancer Res 12(1):49–56

    Article  CAS  PubMed  Google Scholar 

  147. Wei Z, Huang Y, Xie N, Ma Q (2015) Elevated expression of secreted autocrine growth factor progranulin increases cervical cancer growth. Cell Biochem Biophys 71(1):189–193

    Article  CAS  PubMed  Google Scholar 

  148. Wex T, Kuester D, Schonberg C, Schindele D, Treiber G, Malfertheiner P (2011) Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression. BMC Gastroenterol 11:63

    Article  PubMed  PubMed Central  Google Scholar 

  149. Wong NC, Cheung PF, Yip CW, Chan KF, Ng IO, Fan ST, Cheung ST (2014) Antibody against granulin-epithelin precursor sensitizes hepatocellular carcinoma to chemotherapeutic agents. Mol Cancer Ther 13(12):3001–3012

    Article  CAS  PubMed  Google Scholar 

  150. Xing F, Saidou J, Watabe K (2010) Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci (Landmark Ed) 15:166–179

    Article  CAS  Google Scholar 

  151. Xu SQ, Buraschi S, Morcavallo A, Genua M, Shirao T, Peiper SC, Gomella LG, Birbe R, Belfiore A, Iozzo RV, Morrione A (2015) A novel role for drebrin in regulating progranulin bioactivity in bladder cancer. Oncotarget 6(13):10825–10839

    Article  PubMed  PubMed Central  Google Scholar 

  152. Xu SQ, Tang D, Chamberlain S, Pronk G, Masiarz FR, Kaur S, Prisco M, Zanocco-Marani T, Baserga R (1998) The granulin/epithelin precursor abrogates the requirement for the insulin-like growth factor 1 receptor for growth in vitro. J Biol Chem 273(32):20078–20083

    Article  CAS  PubMed  Google Scholar 

  153. Yamada Y, Serrero G (1987) Purification of an insulin-related factor secreted by a teratoma-derived mesodermal cell line. J Biol Chem 262(1):209–213

    Article  CAS  PubMed  Google Scholar 

  154. Yamada Y, Serrero G (1988) Autocrine growth induced by the insulin-related factor in the insulin-independent teratoma cell line 1246-3A. Proc Natl Acad Sci U S A 85(16):5936–5940

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  155. Yamamoto Y, Goto N, Takemura M, Yamasuge W, Yabe K, Takami T, Miyazaki T, Takeuchi T, Shiraki M, Shimizu M, Adachi S, Saito K, Shibata Y, Nakamura N, Hara T, Serrero G, Saito K, Tsurumi H (2017) Association between increased serum GP88 (progranulin) concentrations and prognosis in patients with malignant lymphomas. Clin Chim Acta 473:139–146

    Article  CAS  PubMed  Google Scholar 

  156. Yang D, Li R, Wang H, Wang J, Han L, Pan L, Li X, Kong Q, Wang G, Su X (2017) Clinical implications of progranulin in gastric cancer and its regulation via a positive feedback loop involving AKT and ERK signaling pathways. Mol Med Rep 16(6):9685–9691

    Article  CAS  PubMed  Google Scholar 

  157. Yang D, Wang LL, Dong TT, Shen YH, Guo XS, Liu CY, Liu J, Zhang P, Li J, Sun YP (2015) Progranulin promotes colorectal cancer proliferation and angiogenesis through TNFR2/Akt and ERK signaling pathways. Am J Cancer Res 5(10):3085–3097

    CAS  PubMed  PubMed Central  Google Scholar 

  158. Zanocco-Marani T, Bateman A, Romano G, Valentinis B, He ZH, Baserga R (1999) Biological activities and signaling pathways of the granulin/epithelin precursor. Cancer Res 59(20):5331–5340

    CAS  PubMed  Google Scholar 

  159. Zhang H, Serrero G (1998) Inhibition of tumorigenicity of the teratoma PC cell line by transfection with antisense cDNA for PC cell-derived growth factor (PCDGF, epithelin/granulin precursor). Proc Natl Acad Sci U S A 95(24):14202–14207

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  160. Zhang XY, Pan ZX, Liu H, Yu JL, Li GX, Wang HY, Liu MM (2015) Effect of progranulin (PGRN) on the proliferation and senescence of cervical cancer cells. Genet Mol Res 14(4):14331–14338

    CAS  PubMed  Google Scholar 

  161. Zhao YP, Liu B, Tian QY, Wei JL, Richbourgh B, Liu CJ (2015) Progranulin protects against osteoarthritis through interacting with TNF-alpha and beta-Catenin signalling. Ann Rheum Dis 74(12):2244–2253

    Article  CAS  PubMed  Google Scholar 

  162. Zheng D, Gui B, Gray KP, Tinay I, Rafiei S, Huang Q, Sweeney CJ, Kibel AS, Jia L (2016) Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer. Oncogene 35(36):4807–4815

    Article  CAS  PubMed  Google Scholar 

  163. Zhou J, Gao G, Crabb JW, Serrero G (1993) Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line. J Biol Chem 268(15):10863–10869

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This review is dedicated to the memory of my mother Paule Serrero on the fifth anniversary of her death from pancreatic cancer. The author thanks Sarah Hayashi-Davis for editing. The work on progranulin in my laboratory over the years was supported by R01, R43, and R44 grants from the National Cancer Institute and from the Avon Foundation.

Author information

Authors and Affiliations

  1. A&G Pharmaceutical Inc., Columbia, MD, USA

    Ginette Serrero

Authors
  1. Ginette Serrero
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ginette Serrero .

Editor information

Editors and Affiliations

  1. Department of Pathology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

    Alexander Birbrair

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Serrero, G. (2021). Progranulin/GP88, A Complex and Multifaceted Player of Tumor Growth by Direct Action and via the Tumor Microenvironment. In: Birbrair, A. (eds) Tumor Microenvironment. Advances in Experimental Medicine and Biology, vol 1329. Springer, Cham. https://doi.org/10.1007/978-3-030-73119-9_22

Download citation

Publish with us

Policies and ethics

Search

Navigation